Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1475 of 3284 entries
View as:

PET Study to Determine Muscarinic Receptor Occupancy in Lungs After Inhalation of AZD2115 and Tiotropium

Phase: N/A Priority: Normal
NCT ID: NCT03097380 Org: User:
Start: 04/26/17 End: 12/30/17 Due: 12/30/18

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00206167 Org: User:
Start: 04/30/05 End: 09/30/07 Due: 09/30/08

Evaluate Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI7352 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04770428 Org: User:
Start: 04/20/21 End: 12/02/21 Due: 12/02/22

A First Time in Man, Study to Assess the Safety of AZD8329 After Single Ascending Oral Doses

Phase: N/A Priority: Normal
NCT ID: NCT00935662 Org: User:
Start: 07/31/09 End: 08/31/10 Due: 08/31/11

Safety and Tolerability Study of AZD4831 in Patients With Heart Failure.

Phase: N/A Priority: Normal
NCT ID: NCT03756285 Org: User:
Start: 12/11/18 End: 05/07/20 Due: 05/07/21

ATAC - Quality of Life Sub-Protocol

Phase: N/A Priority: Normal
NCT ID: NCT00784680 Org: User:
Start: 04/30/98 End: 04/30/04 Due: 04/30/05

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH.

Phase: N/A Priority: Normal
NCT ID: NCT05864391 Org: User:
Start: 03/31/23 End: 03/20/24 Due: 03/20/25

Study to Investigate the Efficacy, Safety and Tolerability of AZD1152 Alone and in Combination With Low Dose Cytosine Arabinoside (LDAC)in Acute Myeloid Leukaemia (AML) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00952588 Org: User:
Start: 07/31/09 End: 06/30/11 Due: 06/30/12

Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02087241 Org: User:
Start: 03/31/14 End: 06/30/15 Due: 06/30/16

Phase 1 PK Study to Evaluate the PK of CIN-107 in Subjects With Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05961397 Org: User:
Start: 08/10/21 End: 04/15/22 Due: 04/15/23

A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)

Phase: N/A Priority: Normal
NCT ID: NCT00877890 Org: User:
Start: 03/31/09 End: 01/31/10 Due: 01/31/11

A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia

Phase: N/A Priority: Normal
NCT ID: NCT02972658 Org: User:
Start: 03/15/17 End: 10/02/18 Due: 10/02/19

Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03347279 Org: User:
Start: 11/23/17 End: 11/12/20 Due: 11/12/21

Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT01947868 Org: User:
Start: 11/30/13 End: 09/30/15 Due: 09/30/16

To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00738322 Org: User:
Start: 07/31/08 End: 10/31/08 Due: 10/31/09

Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00999882 Org: User:
Start: 10/31/09 End: 12/31/11 Due: 12/31/12

A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02532998 Org: User:
Start: 09/30/15 End: 12/31/15 Due: 12/31/16

Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01156246 Org: User:
Start: 06/30/10 End: 08/31/10 Due: 08/31/11

Estimating the Use of Resources and the Costs of Treating Patients With Asthma in the Autonomous Community of Valencia

Phase: N/A Priority: Normal
NCT ID: NCT01114906 Org: User:
Start: 09/30/10 End: 06/30/11 Due: 06/30/12

Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults

Phase: N/A Priority: Normal
NCT ID: NCT04840849 Org: User:
Start: 06/22/21 End: 11/18/21 Due: 11/18/22

Adherence in Adolescents and Children Treated on Quetiapine

Phase: N/A Priority: Normal
NCT ID: NCT00680888 Org: User:
Start: 08/31/05 End: 08/31/08 Due: 08/31/09

52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period

Phase: N/A Priority: Normal
NCT ID: NCT00575588 Org: User:
Start: 12/31/07 End: 08/31/10 Due: 08/31/11

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00614939 Org: User:
Start: 01/31/08 End: 03/31/10 Due: 03/31/11

Epanova® for Lowering Very High Triglycerides

Phase: N/A Priority: Normal
NCT ID: NCT01242527 Org: User:
Start: 01/31/11 End: 04/30/12 Due: 04/30/13

Indian Phenotype Registry

Phase: N/A Priority: Normal
NCT ID: NCT03363594 Org: User:
Start: 12/11/17 End: 06/14/19 Due: 06/14/20